Recent posts

TypePostAuthorRepliesLast updated
Page2016: KEI comments on NIH proposal for exclusive licenses to IntelliPanel Medical, LLC Diane Singhroy031 weeks 4 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Etubics Corporation Diane Singhroy031 weeks 4 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Dimension Therapeutics, Inc. Diane Singhroy031 weeks 4 days ago
Blog entryAlfred Engelberg and Aaron Kesselheim in Nature on Bayh-Dole royalty free rights in patents, Xtandi case James Love031 weeks 4 days ago
Blog entryColombia Ministry of Health Announces that Negotiations With Novartis Have Failed; Declaration of Public Interest Imminent Andrew Goldman031 weeks 5 days ago
Blog entryXtandi patient on Medicare — with supplement — pays $441.97 per month Zack Struver031 weeks 5 days ago
Blog entryUS proposal to seek a "better understanding" of Switzerland's implementation of the Nagoya Protocol receives chilly reception thiru031 weeks 6 days ago
Blog entryWIPO IGC30: Narrowing existing gaps relating to the protection of genetic resources? Staff032 weeks 21 hours ago
Blog entryWIPO IGC30: Clean and track-changed version of Facilitators' text on Intellectual Property and Genetic Resources thiru032 weeks 21 hours ago
PageWIPO IGC30 thiru032 weeks 21 hours ago
Blog entry28 Organizations Ask President Obama to Support Colombian Compulsory License on Expensive Leukemia Drug Zack Struver032 weeks 6 days ago
Blog entryHAI/KEI intervention at the WHA69 on the negotiations on an R&D agreement KEI Staff033 weeks 20 hours ago
Blog entryHAI/KEI intervention at the WHA69 on the Framework of Engagement with Non-State Actors thiru033 weeks 20 hours ago
Blog entrySens. Sherrod Brown and Bernie Sanders send letter to USTR condemning pressure on Colombia compulsory license for cancer drug Andrew Goldman033 weeks 3 days ago
Blog entryLetter from KEI, Public Citizen, Oxfam America and Health GAP to Senator Hatch, regarding Colombia Compulsory License James Love033 weeks 4 days ago
Blog entryHarvard's Oct. 23, 2015 forum on "Drug Pricing: Public Health Implications" Zack Struver033 weeks 4 days ago
PageColombia James Love033 weeks 4 days ago
Blog entrySenator Hatch Defends Pressure on Colombia in Interview Regarding Imatinib Andrew Goldman033 weeks 4 days ago
Blog entry15 House Dems Press USTR to Clarify Position on Compulsory Licensing of cancer drug patent in Colombia Andrew Goldman033 weeks 4 days ago
Blog entryWHA 69: Colombian Minister of Health Calls on WHO to Support the Regulation of Drug Monopolies Andrew Goldman033 weeks 5 days ago
Book pageDelinkage James Love033 weeks 6 days ago
PageWHO at the crossroads: negotiations to fund global R&D mired in eight pages of [bracketed] text thiru034 weeks 3 days ago
Blog entryKEI Comments to DHHS on WHA 69 re CEWG, Nocommunicable Diseases Andrew Goldman034 weeks 3 days ago
Blog entryFundación Karisma at WIPO SCCR32 on broadcast treaty James Love034 weeks 4 days ago
Blog entrySave the Date-17 May 2011-KEI @ WIPO Standing Committee on the Law of Patents: Patents and Health thiru034 weeks 4 days ago